Revisiting the structures of several antibiotics bound to the bacterial ribosome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 40, 2010, Pages 17158-17163

  Bulkley, David ^a   Innis, C Axel ^a   Blaha, Gregor ^a   Steitz, Thomas A ^a,b  

^a YALE UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Crystal structure; Structure based drug design

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL PROTEIN; CHLORAMPHENICOL; ERYTHROMYCIN; MACROLIDE;

ARCHAEBACTERIUM; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DEINOCOCCUS RADIODURANS; DRUG BINDING; DRUG DESIGN; DRUG STRUCTURE; ESCHERICHIA COLI; EUBACTERIUM; HALOARCULA MARISMORTUI; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; SPECIES CONSERVATION; SPECIES DIFFERENCE; THERMUS THERMOPHILUS;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL PROTEINS; BINDING SITES; CHLORAMPHENICOL; DEINOCOCCUS; ERYTHROMYCIN; HALOARCULA MARISMORTUI; KETOLIDES; MOLECULAR STRUCTURE; RIBOSOMES; THERMUS THERMOPHILUS;

ARCHAEA; BACTERIA (MICROORGANISMS); DEINOCOCCUS RADIODURANS; ESCHERICHIA COLI; HALOARCULA MARISMORTUI; THERMUS THERMOPHILUS;

EID: 78049250815     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008685107     Document Type: Article

References (54)

1. Wilson DN (2009) The A-Z of bacterial translation inhibitors. Crit Rev Biochem Mol Biol 44:393-433.
2. Ardanuy C, et al. (2010) Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother 65:634-643.
3. Jenkins SG, Farrell DJ (2009) Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis 15:1260-1264.
4. Takaya A, et al. (2010) Mutational analysis of reduced telithromycin susceptibility of Streptococcus pneumoniaeisolated clinically in Japan. FEMS Microbiol Lett 307:87-93.
5. Morozumi M, et al. (2010) Macrolide-resistant Mycoplasma pneumoniae: Characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 16:78-86.
6. Franceschi F, Duffy EM (2006) Structure-based drug design meets the ribosome. Biochem Pharmacol 71:1016-1025.
7. Zhou J, et al. (2008) Design at the atomic level: Generation of novel hybrid biaryloxazolidinones as promising new antibiotics. Bioorg Med Chem Lett 18:6179-6183.
8. Franceschi F, et al. (2004) Macrolide resistance from the ribosome perspective. Curr Drug Targets Infect Disord 4:177-191.
9. Berisio R, et al. (2003) Structural insight into the antibiotic action of telithromycin against resistant mutants. J Bacteriol 185:4276-4279.
10. Tu D, et al. (2005) Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121:257-270.
11. Schlunzen F, et al. (2001) Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821.
12. Schlunzen F, et al. (2003) Structural basis for the antibiotic activity of ketolides and azalides. Structure 11:329-338.
13. Yonath A (2005) Antibiotics targeting ribosomes: Resistance, selectivity, synergism and cellular regulation. Annu Rev Biochem 74:649-679.
14. Schwarz S, et al. (2004) Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev 28:519-542.
15. Vogel Z, et al. (1971) Correlation between the peptidyl transferase activity of the 50 s ribosomal subunit and the ability of the subunit to interact with antibiotics. J Mol Biol 60:339-346.
16. Kearsey SE, Craig IW (1981) Altered ribosomal RNA genes in mitochondria from mammalian cells with chloramphenicol resistance. Nature 290:607-608.
17. Moazed D, Noller HF (1987) Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389-394.
18. Celma ML, et al. (1971) Substrate and antibiotic binding sites at the peptidyl transferase centre of E. coli ribosomes: Binding of UACCA-Leu to 50 S subunits. FEBS Lett 13:247-251.
19. Ulbrich B, et al. (1978) Cooperative binding of 3′-fragments of transfer ribonucleic acid to the peptidyltransferase center of Escherichia coli ribosomes. Arch Biochem Biophys 190:149-154.
20. Barta A, et al. (1984) Identification of a site on 23S ribosomal RNA located at the peptidyl transferase center. Proc Natl Acad Sci USA 81:3607-3611.
21. Noller HF (1984) Structure of ribosomal RNA. Annu Rev Biochem 53:119-162.
22. Bayfield MA, et al. (2001) A conformational change in the ribosomal peptidyl transferase center upon active/inactive transition. Proc Natl Acad Sci USA 98:10096-10101.
23. Blaha G, et al. (2008) Mutations outside the anisomycin-binding site can make ribosomes drug-resistant. J Mol Biol 379:505-519.
24. Klein DJ, et al. (2004) The contribution of metal ions to the structural stability of the large ribosomal subunit. RNA 10:1366-1379.
25. Boese R, et al. (1992) Low-temperature crystal and molecular-structure of nitrobenzene. Struct Chem 3:363-368.
26. Borisenko KB, Hargittai I (1996) Barrier to internal rotation of the nitro group in ortho-nitrophenols from gas-phase electron diffraction. J Mol Struct 382:171-176.
27. Xaplanteri MA, et al. (2003) Effect of polyamines on the inhibition of peptidyltransferase by antibiotics: Revisiting the mechanism of chloramphenicol action. Nucleic Acids Res 31:5074-5083.
28. Blanc H, et al. (1981) Mitochondrial DNA of chloramphenicol-resistant mouse cells contains a single nucleotide change in the region encoding the 3′ end of the large ribosomal RNA. Proc Natl Acad Sci USA 78:3789-3793.
29. Moazed D, Noller HF (1987) Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69:879-884.
30. Rodriguez-Fonseca C, et al. (1995) Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes. J Mol Biol 247:224-235.
31. Leslie AG, et al. (1988) Structure of chloramphenicol acetyltransferase at 1.75-A resolution. Proc Natl Acad Sci USA 85:4133-4137.
32. Shaw WV, Brodsky RF (1968) Characterization of chloramphenicol acetyltransferase from chloramphenicol-resistant Staphylococcus aureus. J Bacteriol 95:28-36.
33. Wilson DN, et al. (2005) Species-specific antibiotic-ribosome interactions: Implications for drug development. Biol Chem 386:1239-1252.
34. Vazquez-Laslop N, et al. (2008) Molecular mechanism of drug-dependent ribosome stalling. Mol Cell 30:190-202.
35. Blaha G, et al. (2009) Formation of the first peptide bond: The structure of EF-P bound to the 70S ribosome. Science 325:966-970.
36. Selmer M, et al. (2006) Structure of the 70S ribosome complexed with mRNA and tRNA. Science 313:1935-1942.
37. Voorhees RM, et al. (2009) Insights into substrate stabilization from snapshots of the peptidyl transferase center of the intact 70S ribosome. Nat Struct Mol Biol 16:528-533.
38. Hansen JL, et al. (2002) The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell 10:117-128.
39. Xiong L, et al. (2005) Binding site of the bridged macrolides in the Escherichia coli ribosome. Antimicrob Agents Chemother 49:281-288.
40. Garza-Ramos G, et al. (2001) Binding site of macrolide antibiotics on the ribosome: New resistance mutation identifies a specific interaction of ketolides with rRNA. J Bacteriol 183:6898-6907.
41. Hansen LH, et al. (1999) The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol Microbiol 31:623-631.
42. Blanc H, et al. (1981) Different nucleotide changes in the large rRNA gene of the mitochondrial DNA confer chloramphenicol resistance on two human cell lines. Nucleic Acids Res 9:5785-5795.
43. Johansson D, et al. (2005) Design, synthesis and ribosome binding of chloramphenicol nucleotide and intercalator conjugates. Bioorg Med Chem Lett 15:2079-2083.
44. Nissen P, et al. (2000) The structural basis of ribosome activity in peptide bond synthesis. Science 289:920-930.
45. Or YS, et al. (2000) Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. J Med Chem 43:1045-1049.
46. Skripkin E, et al. (2008) R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance. Antimicrob Agents Chemother 52:3550-3557.
47. Weisblum B (1995) Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 39:577-585.
48. Kovalic D, et al. (1995) Methylation ofminimalist 23S rRNA sequences in vitro by ErmSF (TlrA) N-methyltransferase. Biochemistry 34:15838-15844.
49. Stanley RE, et al. (2010) The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Nat Struct Mol Biol 17:289-293.
50. Kabsch W (2010) Xds. Acta Crystallogr D 66:125-132.
51. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674.
52. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D 66:213-221.
53. Schuttelkopf AW, van Aalten DM (2004) PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D 60:1355-1363.
54. Kleywegt GJ, Jones TA (1994) Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr D 50:178-185.